R 0008/13 () of 15.9.2015

European Case Law Identifier: ECLI:EP:BA:2015:R000813.20150915
Date of decision: 15 September 2015
Case number: R 0008/13
Petition for review of: T 1676/08
Application number: 96102992.3
IPC class: A61K 31/485
A61K 9/20
A61P 25/04
Language of proceedings: EN
Distribution: B
Download and more information:
Decision text in EN (PDF, 107 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished | Unpublished v2
Title of application: Controlled release oxycodone compositions
Applicant name: The Purdue Pharma Company
Mundipharma GmbH
Napp Pharmaceutical Holdings Limited
Norpharma A/S
Mundipharma Pharmaceuticals S.R.L.
Mundipharma Laboratories GmbH
Mundipharma Pharmaceuticals BV
Mundipharma AB
Mundipharma AG
Mundipharma Farmaceutica LDA
Mundipharma Pharmaceuticals SL
Mundipharma GesmbH
Mundipharma CVA
Opponent name: Lannacher Heilmittel Ges.m.b.H.
Board: EBA
Headnote: -
Relevant legal provisions:
European Patent Convention Art 112a
European Patent Convention R 104
Keywords: Violations of the right to be heard: no. Other procedural defects: no
Petition not allowable
Catchwords:

-

Cited decisions:
G 0006/95
G 0002/10
R 0001/08
R 0013/09
R 0016/10
R 0019/11
R 0015/12
R 0016/13
Citing decisions:
R 0019/12
R 0003/15
R 0004/16
R 0006/16
R 0008/17
R 0006/18
T 1627/09
T 1257/14
T 1787/16

Source: http://www.epo.org/law-practice/case-law-appeals/recent/r130008eu2.html

Date retrieved: 17 May 2021

29 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPC Implementing Rules

Case Law Book: III Amendments

Case Law Book: V Priority

Case Law Book: VII Proceedings before the EPO

Case Law of the Enlarged Board

General Case Law